Literature DB >> 6802019

[The influence of buprenorphine and tramadol on the postoperative CO2 response after general anaesthesia (author's transl)].

R Klose, A Ehrhart, R Jung.   

Abstract

The degree of respiratory depression caused by buprenorphine and tramadol were studied in two groups of 25 patients each by means of Read's re-breathing technique. The estimations were made during the immediate postoperative stage in order to include potential residual effects of the general anaesthesia. The slope of the CO2 curve as a measure of respiratory depression decreased by 27 per cent after administration of 0.3 mg of buprenorphine, a reduction which equals that produced by potent morphine-type analgesics. The response to 50 mg of tramadol was a non-significant decrease by 3 per cent. At doses mentioned buprenorphine produced reliable pain relief, whereas with tramadol the failure rate was 28 per cent. There was no difference between the two drugs in respect of circulatory reactions and side-effects. Despite its depressing effect on the respiration (an action it shares with all potent analgesics) buprenorphine is a very useful analgesic because it provides excellent pain relief, has no or only minimal addictive properties and is not subject to the Dangerous Drugs Act.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802019

Source DB:  PubMed          Journal:  Anasth Intensivther Notfallmed        ISSN: 0174-1837


  6 in total

1.  [Not Available].

Authors:  M Zenz
Journal:  Schmerz       Date:  1987-07       Impact factor: 1.107

Review 2.  A risk-benefit assessment of tramadol in the management of pain.

Authors:  L Radbruch; S Grond; K A Lehmann
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

3.  Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trials.

Authors:  John A Zebala; Shawn L Searle; Lynn R Webster; Matt S Johnson; Aaron D Schuler; Dean Y Maeda; Stuart J Kahn
Journal:  J Pain       Date:  2019-04-18       Impact factor: 5.820

Review 4.  Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states.

Authors:  C R Lee; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

5.  A comparison of the antinociceptive effects of imipramine, tramadol and anpirtoline.

Authors:  T Hummel; C Hummel; I Friedel; E Pauli; G Kobal
Journal:  Br J Clin Pharmacol       Date:  1994-04       Impact factor: 4.335

Review 6.  Tramadol for the management of acute pain.

Authors:  K A Lehmann
Journal:  Drugs       Date:  1994       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.